Home

Bioworkshops sell "Burosumab"

Basic Information

128
4
1
4.6(28)

Trade Type

Sell

Product Name

Burosumab

Manufacturer(s)

Specifications

  • Expression System: DMF-filed production cell line optimized for high-titer monoclonal antibody expression
  • Formulation Type: FGF23-antagonist monoclonal antibody
  • Regulatory Status: Reference product approved in 2018 in the EU/EEA
  • Application: Treatment of familial hypophosphatemic rickets and related FGF23-mediated disorders

Documents

GMP
Filters:
Sort by:

    No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product